140 related articles for article (PubMed ID: 16280239)
1. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue.
Ro Y; Muramatsu T; Shima K; Yajima Y; Shibahara T; Noma H; Shimono M
Int J Oral Maxillofac Surg; 2006 Mar; 35(3):252-7. PubMed ID: 16280239
[TBL] [Abstract][Full Text] [Related]
2. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
[TBL] [Abstract][Full Text] [Related]
3. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
4. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 expression has prognostic significance in head and neck carcinoma.
Anttonen A; Kajanti M; Heikkilä P; Jalkanen M; Joensuu H
Br J Cancer; 1999 Feb; 79(3-4):558-64. PubMed ID: 10027330
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 expression during postnatal tooth and oral mucosa development in rats aged from two days to six weeks.
De Angelis DD; Sampson WJ; Wiebkin OW; Wilson DF
Aust Orthod J; 2002 Mar; 18(1):1-6. PubMed ID: 12502123
[TBL] [Abstract][Full Text] [Related]
7. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue.
Matsuzaki H; Shima K; Muramatsu T; Ro Y; Hashimoto S; Shibahara T; Shimono M
J Oral Pathol Med; 2007 Jan; 36(1):30-4. PubMed ID: 17181739
[TBL] [Abstract][Full Text] [Related]
9. [The expression of cell adhesion molecule Syndecan-1 and E-candherin in laryngeal cancer].
Li Y; Yang C
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 17(12):736-8. PubMed ID: 15017723
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN expression in tongue squamous cell carcinoma.
Huang Z; Huang H; Li H; Chen W; Pan C
J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein expression in the squamous cell carcinoma of the tongue base.
Rabkin D; Chhieng DC; Miller MB; Jennings T; Feustel P; Steiniger J; Parnes SM
Laryngoscope; 1995 Dec; 105(12 Pt 1):1294-9. PubMed ID: 8523980
[TBL] [Abstract][Full Text] [Related]
12. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
14. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
15. DNA amplification and expression of FADD in oral squamous cell carcinoma.
Prapinjumrune C; Morita K; Kuribayashi Y; Hanabata Y; Shi Q; Nakajima Y; Inazawa J; Omura K
J Oral Pathol Med; 2010 Aug; 39(7):525-32. PubMed ID: 20040024
[TBL] [Abstract][Full Text] [Related]
16. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas.
Máthé M; Suba Z; Németh Z; Tátrai P; Füle T; Borgulya G; Barabás J; Kovalszky I
Oral Oncol; 2006 May; 42(5):493-500. PubMed ID: 16364677
[TBL] [Abstract][Full Text] [Related]
17. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
[TBL] [Abstract][Full Text] [Related]
19. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of syndecan-1 in prostate cancer.
Kiviniemi J; Kallajoki M; Kujala I; Matikainen MT; Alanen K; Jalkanen M; Salmivirta M
APMIS; 2004 Feb; 112(2):89-97. PubMed ID: 15056224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
